Is Agilon Health (AGL) Stock Outpacing Its Medical Peers This Year?

Zacks
03-20

The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is Agilon Health (AGL) one of those stocks right now? Let's take a closer look at the stock's year-to-date performance to find out.

Agilon Health is a member of the Medical sector. This group includes 1012 individual stocks and currently holds a Zacks Sector Rank of #4. The Zacks Sector Rank includes 16 different groups and is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors.

The Zacks Rank is a proven model that highlights a variety of stocks with the right characteristics to outperform the market over the next one to three months. The system emphasizes earnings estimate revisions and favors companies with improving earnings outlooks. Agilon Health is currently sporting a Zacks Rank of #2 (Buy).

The Zacks Consensus Estimate for AGL's full-year earnings has moved 21.3% higher within the past quarter. This shows that analyst sentiment has improved and the company's earnings outlook is stronger.

Based on the most recent data, AGL has returned 131.6% so far this year. Meanwhile, the Medical sector has returned an average of 4.9% on a year-to-date basis. This means that Agilon Health is performing better than its sector in terms of year-to-date returns.

Another Medical stock, which has outperformed the sector so far this year, is Paragon 28, Inc. (FNA). The stock has returned 26.1% year-to-date.

For Paragon 28, Inc. the consensus EPS estimate for the current year has increased 3.1% over the past three months. The stock currently has a Zacks Rank #2 (Buy).

Looking more specifically, Agilon Health belongs to the Medical Services industry, which includes 59 individual stocks and currently sits at #63 in the Zacks Industry Rank. Stocks in this group have gained about 5.6% so far this year, so AGL is performing better this group in terms of year-to-date returns.

Paragon 28, Inc. however, belongs to the Medical - Instruments industry. Currently, this 84-stock industry is ranked #81. The industry has moved -3.1% so far this year.

Investors with an interest in Medical stocks should continue to track Agilon Health and Paragon 28, Inc. These stocks will be looking to continue their solid performance.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Agilon Health, Inc. (AGL) : Free Stock Analysis Report

Paragon 28, Inc. (FNA) : Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10